Purpose Our objective was to provide a contemporary analysis of a pediatric hypertrophic
cardiomyopathy (HCM) cohort and determine risk factors independently associated with …

Purpose Our aim was to determine the transplant-free survival for pediatric hypertrophic
cardiomyopathy (HCM) patients with decreased left ventricular (LV) systolic function and …

We describe characteristics and outcomes of contemporary pediatric hypertrophic
cardiomyopathy (PHC) patients. We studied 398 consecutive pediatric HC patients (< 18 …

Background Hypertrophic cardiomyopathy (HCM) is the second most common pediatric
cardiomyopathy. Although there is a large body of literature about HCM in adults, there is …

Background Few data on paediatric hypertrophic cardiomyopathy (HCM) are available in
developing countries. A multicentre, retrospective, cohort study was conducted to profile the …

Background—Population-based studies have provided insight into the natural history of
adult hypertrophic cardiomyopathy, but comparable information for affected children is …

Background—Current information on the epidemiology and outcomes of hypertrophic
cardiomyopathy (HCM) in children is limited by disease diversity and small case series …

Aims Understanding the spectrum of disease, symptom burden and natural history are
essential for the management of children with hypertrophic cardiomyopathy (HCM). The …

BACKGROUND: The course of pediatric hypertrophic cardiomyopathy (HCM) is variable,
and the indications for heart transplantation (HTx) are ill defined. This study investigated …

The epidemiologic data for pediatric hypertrophic cardiomyopathy (HCM) needs to be
periodically updated as diagnostic techniques and management strategies improve. Herein …